抗表面活性蛋白B自身免疫与检查点阻断治疗期间肺炎相关
该研究探讨抗表面活性蛋白B自身抗体和自身反应性T细胞在非小细胞肺癌患者ICI相关肺炎中的作用。结果显示肺炎患者治疗前抗SP-B的IgG自身抗体水平更高,肺炎发生时SP-B特异性CD4+ IFN-γ阳性T细胞频率更高且T细胞克隆扩增,伴促炎血清蛋白组特征,提示两者共存与肺炎发生相关。
要点
- 治疗前抗SP-B的IgG自身抗体水平升高与ICI相关肺炎风险增加相关
- 肺炎发生时SP-B特异性CD4+ IFN-γ阳性T细胞频率升高且克隆扩增
- 抗SP-B抗体可能作为肺炎风险或诊断的潜在生物标志物
核心结论
- SP-B特异性IgG自身抗体与CD4+ T细胞共存与ICI治疗期间肺炎发生相关
- 治疗前抗体水平可能是肺炎风险增加的潜在生物标志物
- 治疗中抗体水平可能有助于诊断
研究设计与样本
- 研究队列为提供ICI治疗前后血样的NSCLC患者
- 血清用于蛋白质组学分析和肺炎时自身抗体检测
- 进行T细胞刺激试验和单细胞RNA测序研究外周自身反应性T细胞
- 在包含NSCLC和黑色素瘤患者的验证队列中确认发现
主要发现
- 两个队列中,发生肺炎的患者治疗前抗SP-B的IgG自身抗体水平更高
- 肺炎发生时,这些患者SP-B特异性CD4+ IFN-γ阳性T细胞频率更高
- 肺炎发生时,识别SP-B的T细胞克隆扩增,伴促炎血清蛋白组特征
临床怎么用
- 治疗前检测抗SP-B的IgG自身抗体可能辅助识别肺炎高风险患者
- 治疗中监测抗SP-B抗体水平可能辅助肺炎诊断
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Immune checkpoint inhibitor (ICI)-related pneumonitis is a serious autoimmune event affecting as many as 20% of patients with non-small-cell lung cancer (NSCLC), yet the factors underpinning its development in some patients and not others are poorly understood. Objectives: To investigate the role of autoantibodies and autoreactive T cells against surfactant-related proteins in the development of pneumonitis. Methods: The study cohort consisted of patients with NSCLC who provided blood samples before and during ICI treatment. Serum was used for proteomics analyses and to detect autoantibodies present during pneumonitis. T-cell stimulation assays and single-cell RNA sequencing were performed to investigate the specificity and functionality of peripheral autoreactive T cells. The findings were confirmed in a validation cohort comprising patients with NSCLC and patients with melanoma. Measurements and Main Results: Across both cohorts, patients in whom pneumonitis developed had higher pretreatment levels of immunoglobulin G autoantibodies targeting surfactant protein (SP)-B. At the onset of pneumonitis, these patients also exhibited higher frequencies of CD4+ IFN-γ-positive SP-B-specific T cells and expanding T-cell clonotypes recognizing this protein, accompanied by a proinflammatory serum proteomic profile. Conclusions: Our data suggest that the cooccurrence of SP-B-specific immunoglobulin G autoantibodies and CD4+ T cells is associated with the development of pneumonitis during ICI therapy. Pretreatment levels of these antibodies may represent a potential biomarker for an increased risk of developing pneumonitis, and on-treatment levels may provide a diagnostic aid.
引用
- Wyss N, Berner F, Walter V, et al. Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade. Am J Respir Crit Care Med. 2024. PMID: 38626354. doi:10.1164/rccm.202311-2136OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。